Cytochrome b Drug Resistance Mutation Decreases Babesia Fitness in the Tick Stages But Not the Mammalian Erythrocytic Cycle
Open Access
- 17 June 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 225 (1) , 135-145
Abstract
Human babesiosis is an emerging tick-borne malaria-like illness caused by Babesia parasites following their development in erythrocytes. Here, we show that a mutation in the Babesia microti mitochondrial cytochrome b (Cytb) that confers resistance to the antibabesial drug ELQ-502 decreases parasite fitness in the arthropod vector. Interestingly, whereas the mutant allele does not affect B. microti fitness during the mammalian blood phase of the parasite life cycle and is genetically stable as parasite burden increases, ELQ-502–resistant mutant parasites developing in the tick vector are genetically unstable with a high rate of the wild-type allele emerging during the nymphal stage. Furthermore, we show that B. microti parasites with this mutation are transmitted from the tick to the host, raising the possibility that the frequency of Cytb resistance mutations may be decreased by passage through the tick vector, but could persist in the environment if present when ticks feed.Keywords
Funding Information
- National Institutes of Health (R01AI123321, R01AI138139, R01AI152220, R01AI136118, R01AI100569, R01AI141412)
- Steven and Alexandra Cohen Foundation (Lyme 62 2020)
- U.S. Department of Veterans Affairs (i01 BX003312)
- U.S. Department of War (PR181134)
This publication has 34 references indexed in Scilit:
- Whole Genome Mapping and Re-Organization of the Nuclear and Mitochondrial Genomes of Babesia microti IsolatesPLOS ONE, 2013
- Babesia microti:an unusual travel-related diseaseBMC Infectious Diseases, 2013
- Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti†Nucleic Acids Research, 2012
- Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc1 Catalytic Turnover and Protein ExpressionJournal of Biological Chemistry, 2012
- Purification of RNA Using TRIzol (TRI Reagent)Cold Spring Harbor Protocols, 2010
- Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparumNature, 2007
- The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006
- Atovaquone and Azithromycin for the Treatment of BabesiosisNew England Journal of Medicine, 2000
- Atovaquone resistance in malaria parasitesDrug Resistance Updates, 2000
- Development of Babesia microti sporozoites in adult Ixodes damminiInternational Journal for Parasitology, 1986